Dual Targeting of Inflammatory and Immune Checkpoint Pathways to Overcome Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma
Zhifeng Qu,1 Linlin Shi,2 Pei Wang,1 Anshun Zhao,2 Xuewei Zheng,3 Qinan Yin1,3 1Department of Radiation Oncology; Cancer Institute, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, People’s Republic of China; 2Henan Key Laborator...
Saved in:
| Main Authors: | Qu Z, Shi L, Wang P, Zhao A, Zheng X, Yin Q |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/dual-targeting-of-inflammatory-and-immune-checkpoint-pathways-to-overc-peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of chemotherapy with/without radiotherapy for stage IVb esophageal squamous cell carcinoma: a population-based target trial emulation study
by: Yao-Hung Kuo, et al.
Published: (2025-05-01) -
Sequential boost of intensity‐modulated radiotherapy with chemotherapy for inoperable esophageal squamous cell carcinoma: A prospective phase II study
by: Xing‐Wen Fan, et al.
Published: (2020-04-01) -
A Propensity-Score Matched Analysis to Evaluate Local Treatment Modalities for Esophageal Squamous Cell Carcinoma in Over 80 years on A SEER Database
by: Li Q, et al.
Published: (2025-08-01) -
Preoperative radiotherapy in patients with locally advanced esophageal squamous cell carcinoma: a narrative review
by: Yan Lin, et al.
Published: (2025-07-01) -
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355)
by: Xinyi Liu, et al.
Published: (2025-07-01)